Continue reading Stack3d
FDA

Sulbutiamine and two others make it ten for the FDA’s growing Advisory List

Laxogenin joins the FDA’s Advisory List and takes it to a total of seven

The FDA adds n-methyltyramine and octopamine to its advisory list

FDA introduces a tool to alert the public about unlawful ingredients

The FDA issues warning letters regarding DMHA and phenibut

FDA commissioner issues a statement regarding supplement regulation

FDA now considers high caffeine bulk supplements unlawful

fda bulk caffeine

New study published on stimulants structurally similar to DMAA

Pieter Cohen DMAA similar study

The FDA issues a warning against the use of SARMs

FDA SARMs